1. Home
  2. AMPH vs BBN Comparison

AMPH vs BBN Comparison

Compare AMPH & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • BBN
  • Stock Information
  • Founded
  • AMPH 1996
  • BBN 1983
  • Country
  • AMPH United States
  • BBN United States
  • Employees
  • AMPH N/A
  • BBN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • BBN Finance Companies
  • Sector
  • AMPH Health Care
  • BBN Finance
  • Exchange
  • AMPH Nasdaq
  • BBN Nasdaq
  • Market Cap
  • AMPH 1.1B
  • BBN 968.9M
  • IPO Year
  • AMPH 2014
  • BBN N/A
  • Fundamental
  • Price
  • AMPH $24.34
  • BBN $16.14
  • Analyst Decision
  • AMPH Hold
  • BBN
  • Analyst Count
  • AMPH 5
  • BBN 0
  • Target Price
  • AMPH $38.00
  • BBN N/A
  • AVG Volume (30 Days)
  • AMPH 507.4K
  • BBN 231.8K
  • Earning Date
  • AMPH 08-06-2025
  • BBN 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • BBN 6.90%
  • EPS Growth
  • AMPH N/A
  • BBN N/A
  • EPS
  • AMPH 2.77
  • BBN N/A
  • Revenue
  • AMPH $730,659,000.00
  • BBN N/A
  • Revenue This Year
  • AMPH $0.67
  • BBN N/A
  • Revenue Next Year
  • AMPH $5.18
  • BBN N/A
  • P/E Ratio
  • AMPH $8.26
  • BBN N/A
  • Revenue Growth
  • AMPH 8.05
  • BBN N/A
  • 52 Week Low
  • AMPH $22.64
  • BBN $14.33
  • 52 Week High
  • AMPH $53.96
  • BBN $18.36
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 34.01
  • BBN 64.31
  • Support Level
  • AMPH $22.81
  • BBN $15.90
  • Resistance Level
  • AMPH $25.04
  • BBN $16.14
  • Average True Range (ATR)
  • AMPH 0.67
  • BBN 0.14
  • MACD
  • AMPH -0.33
  • BBN 0.05
  • Stochastic Oscillator
  • AMPH 6.38
  • BBN 97.32

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.

Share on Social Networks: